Ten names. Three ETFs carry a view — the spotlight and the two funds actually bought — and the rest are the worked examples used to teach the five moat sources and the size problem, so they are Neutral. The other portfolio ETFs are named in the charts but their tickers are not given in the post and are not inferred. Research legend: QT Qualtrim · SA Seeking Alpha · STK Stock Analysis. Written post with no timestamps — the At link opens the article.
| Ticker | Name | Research | View | What he said | At |
|---|---|---|---|---|---|
| SMOT | VanEck Morningstar SMID Moat ETF | SA · STK | Positive | ETF of the Month. "You want to invest in companies with a wide moat. But you know what's even better? Finding a small company with a wide moat." Mechanics: starts from the Morningstar US Small-Mid Cap Index, keeps only Wide or Narrow moat companies, then screens out bad momentum and picks "the best-priced companies (115 in total)." TER 0.49%, physical, ISIN US92189H7301. Sectors: IT 18.2%, Health Care 18.1%, Industrials 15.8%. Top holdings are a genuinely different set from the archive's usual universe — Carnival 1.51%, Acuity Brands 1.46%, Masco 1.46%, Gentex 1.45%, Block 1.42%, Bio-Techne, Royalty Pharma, Airbnb, Norwegian Cruise Line, Biogen. Not added to either model portfolio in this issue. | read ↗ |
| VB | Vanguard Small-Cap ETF | SA · STK | Positive | BOUGHT (American portfolio) — $500 at the next market opening, price $296.5. "We are increasing our exposure to small caps." Already the largest position at 21.8% and the best performer in that book at roughly +67%; this is its fourth purchase (Dec 2023 at $212.8, Mar 2024 at $224.6, Oct 2024 at $242.7, Feb 2026 at $277.32). Adding to the biggest winner rather than rebalancing away from it. | read ↗ |
| IUSN.DE | iShares MSCI World Small Cap UCITS ETF | STK | Positive | BOUGHT (non-American portfolio) — €500 at the next market opening, price €9.1. The UCITS equivalent of the VB purchase, "because if you live in the US, you can't buy non-US ETFs. And if you live outside the US, you can't buy US ETFs." Currently 18.1% of that book at roughly +33%, its fourth purchase since November 2023 (€5.62, €6.37, €6.85, €8.41). | read ↗ |
| FICO | Fair Isaac | QT · SA · STK · FA | Neutral | The worked example of switching costs: "Banks have built their automated loan approval systems around them, and switching to a competitor means massive operational risk for no real advantage." Teaching use only — the rating itself is BUY on the 18 June list. | read ↗ |
| RMS.PA | Hermès International | QT · SA · STK | Neutral | The worked example of intangible assets: "A competitor can make a similar bag, but they'll never have the prestige that allows Hermès to consistently raise prices without losing demand." Rated Hold on the June list after an upgrade from Sell. | read ↗ |
| V | Visa | QT · SA · STK · FA | Neutral | The worked example of network effects: "Consumers use Visa because every merchant accepts it. Merchants accept Visa because every consumer carries it." A holding and a Buy elsewhere; no fresh view here. | read ↗ |
| COST | Costco Wholesale | QT · SA · STK · FA | Neutral | The worked example of a cost advantage: "Costco buys in bulk, and passes the cost savings to customers, which makes the customers more loyal, and drives higher volumes, which allows Costco to lower prices even more." Cited as the textbook flywheel; no stance taken. | read ↗ |
| UNP | Union Pacific | QT · SA · STK · FA | Neutral | The worked example of efficient scale: "Building a new coast-to-coast rail network would require hundreds of billions of dollars in land rights and infrastructure, only to split an already mature market." One of the ten oldest companies in the Lindy Effect list. | read ↗ |
| AAPL | Apple | QT · SA · STK · FA | Neutral | The worked example of the size problem: on ~$400bn of revenue, a 20% year means finding $80bn of new sales — "iPads and Macs combined generated $62 billion in revenue last year. Apple would have to invent an entirely new category bigger than both to grow by 20%." Used as arithmetic, not as a view. | read ↗ |
| BRK.B | Berkshire Hathaway | QT · SA · STK · FA | Neutral | The second size illustration, and the more uncomfortable one: "Berkshire has nearly quadrupled its revenue in the past 20 years. But the revenue growth rate is slowing down." With Buffett's own 1995 line — "The giant disadvantage we face is size: In the early years, we needed only good ideas, but now we need good big ideas." Upgraded to Buy on the 18 June list a week earlier; the two statements sit awkwardly together. | read ↗ |
Two observations on the model portfolios. (1) The non-American book is ahead on CAGR but behind per position on the biggest bet: 18.7% versus 14.8% overall, yet the American Vanguard Small-Cap position is up ~67% against ~33% for its UCITS world-small-cap equivalent — the American portfolio's edge is concentrated in US small caps, the non-American's in emerging markets and multifactor. (2) The one losing position in either book is the March 2026 purchase of the iShares Edge MSCI World Minimum Volatility UCITS ETF, at −3.94% — bought at €75.72, now €72.74. That is the same low-volatility factor the archive buys again in July on the argument that the discrepancy versus high volatility is the widest since 2006.
A jargon-free summary of the thesis behind each argued name. (Renders on each name's consolidated page.)
This fund tries to do two things at once that have historically each worked on their own. The first is to own companies with a durable competitive advantage — Morningstar rates these "wide moat" if it expects the advantage to last twenty years or more — which has beaten the American market by about four percentage points a year since 2008. The second is to own smaller companies, which have historically beaten the market by about three points a year, mainly because it is much easier to grow a small business than a very large one.
How it works in practice: start with all American small and medium-sized listed companies, keep only those Morningstar says have a moat, throw out the ones whose share prices are behaving badly, and from what is left buy the cheapest 115. The annual fee is 0.49%.
The reason for raising it now is a single relationship: smaller American companies currently trade at 0.87 times the earnings multiple of large ones, against a twenty-two-year average of 1.15 — as cheap, relative to big companies, as they have been in the whole period measured. And they are far less examined: eleven analysts follow the average one, against twenty-six for a member of the S&P 500.
One thing to notice before assuming this is a fund full of Hermès-like businesses: it accepts "narrow" moats as well as wide ones, and the cheapness filter pulls it toward cyclical companies. The largest holdings include two cruise lines.
A plain, cheap fund holding a broad basket of smaller American companies. It is already the largest position in the model portfolio for US-based readers, at about 22%, and the best performing one, up roughly two thirds since it was first bought in December 2023 at $212.80 — it now trades near $297.
This month's $500 goes into it again, which is worth noting as a behaviour: rather than trimming the winner to rebalance, the addition goes to the position that has already worked, because the reasoning behind it — smaller companies are unusually cheap relative to large ones — has not changed. Adding a fixed amount every month means the purchase price is whatever the market offers on the day.
The European-domiciled equivalent of the small-company purchase above, bought with €500 at about €9.10. It exists in the portfolio for a regulatory rather than an investment reason: European investors generally cannot buy American-listed funds, and American investors cannot buy European ones, so the archive runs two parallel portfolios that aim at the same exposures.
One difference is worth seeing: this fund holds smaller companies from around the world rather than only American ones, and it is up about a third since late 2023 against roughly two thirds for its American counterpart. Same idea, different geography, materially different result so far.
Summary derived from the archived Compounding Quality post (text in transcript.txt) for personal study. Not investment advice. © Compounding Quality / Pieter Slegers for source material.